Media Releases
2022
29/08/2022
Proteomics International Laboratories set to expand its commercial footprint in the US [VIDEO] – Proactive Investors
29/08/2022
Proteomics, UWA join forces on new diagnostic test – The West Australian
29/08/2022
OxiDx launched to maximise oxidative stress technology
15/08/2022
Proteomics International raises $8m in highly successful Placement
09/08/2022
Proteomics International signs binding letter of intent with Sonic Healthcare USA to take PromarkerD into the US market
02/08/2022
American doctors give tick to Proteomics kidney test – The West Australian
02/08/2022
Clinical Utility Study demonstrates PromarkerD test benefits
01/08/2022
Potential breakthrough blood test able to detect people with endometriosis
01/08/2022
Boost for Proteomics in fight against painful disorder – The West Australian
25/07/2022
European PromarkerD patents expanded beyond diabetes
30/06/2022
Promarker™ pipeline – Endometriosis update Diagnostic readout positive: Study expanded
28/06/2022
QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International – Precision Oncology News
21/06/2022
Proteomics International (ASX:PIQ) secures licence for oesophageal cancer biomarkers – The Market Herald
21/06/2022
Proteomics International secures exclusive licence to oesophageal cancer biomarkers
16/06/2022
Pilot test kit takes Proteomics step closer to sales – The West Australian
Newsroom
News Archive
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
1
…
4
5
6
7
8
9
10
…
25
Subscribe
Subscripe to:
All Company news and updates
PromarkerD updates
PromarkerEso updates
PromakerEndo updates
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Name
This field is for validation purposes and should be left unchanged.
Company
About Us
Mission Statement
Senior Staff
Board of Directors
Clinical Advisory Board
Customer Testimonials
Quality Control
Careers
Glossary
Promarker™ Pipeline
PromarkerD
PromarkerEndo
PromarkerEso
OxiDx
Project Statuses
Biomarker Discovery
Analytical Services
Pharmacokinetics
Biomarker Services
Protein Analysis
Project Consultation
Pricing and Ordering – Commercial
Pricing and Ordering - Local WAP
Downloads
Terms and Conditions
FAQs
Newsroom
News & Media
Newsletters
Publications
Events and Presentations
Investors
ASX Announcements
Share Price and Analyst Coverage
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Provide your feedback